Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Non-Small Cell Lunch Cancer × NVP-BKM120 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Stomach Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pre-menopausal Breast Cancer 1 Non-Small Cell Lunch Cancer 1 Non Castrate Metastatic Prostate Cancer 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced Solid Tumor 1 Leukemia, Myeloid, Acute 1 Leukemia 1

Interventions

Paclitaxel 1 NVP-BKM120 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01820325 2018-10-11

BASALT-2

Novartis

Phase 1 Terminated

Non-Small Cell Lunch Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡